| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/28/2005 | WO2005037775A1 Novel molecule for inducing differentiation of dendritic cells |
| 04/28/2005 | WO2005037774A1 Novel molecules to develop drug for the treatment of osteoporosis |
| 04/28/2005 | WO2005037711A1 Amphiphilic [5:1]- and [3:3]- hexakisadducts of fullerenes |
| 04/28/2005 | WO2005037347A2 Treatment of overuse tendinopathy using transdermal nitric oxide-generating agents |
| 04/28/2005 | WO2005037346A2 Method for providing long-lasting pain relief through intrathecal administration of civamide |
| 04/28/2005 | WO2005037322A1 Oncogene therapeutic drug |
| 04/28/2005 | WO2005037321A1 Oncogene therapeutic drug |
| 04/28/2005 | WO2005037318A2 Treatment of arthritic conditions, chronic inflammation or pain |
| 04/28/2005 | WO2005037317A2 Mast cell-derived renin |
| 04/28/2005 | WO2005037316A1 Method of inhibiting secretase activity |
| 04/28/2005 | WO2005037300A1 The use of a polyphenol for the treatment of a cancerous or pre-cancerous lesion of the skin |
| 04/28/2005 | WO2005037295A1 Agent and method for treating cancer comprising strontium, amino acid(s) and mineral agent(s) |
| 04/28/2005 | WO2005037294A1 Compositions for controlling parasites comprising a combination of abamectin and ivermectin |
| 04/28/2005 | WO2005037293A1 Immunomodulating compositions and uses therefor |
| 04/28/2005 | WO2005037292A1 Mucous membrane bulging humor composition comprising chitosan derivative containing saccharide chain for use in condoscopic surgery |
| 04/28/2005 | WO2005037291A1 Silyl phenol for promoting vascular health |
| 04/28/2005 | WO2005037290A1 Use of phosphono derivatives as anti-malarial |
| 04/28/2005 | WO2005037289A1 Analgesia method |
| 04/28/2005 | WO2005037287A1 Oral administration of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7) en-2-yl)alkyl]phosphonic acid and derivatives |
| 04/28/2005 | WO2005037286A1 Use of pteridine derivatives for the treatment of increased intracranial pressure and secondary ischemia |
| 04/28/2005 | WO2005037285A1 2,6-disubstituted quinazolines, quinoxalines, quinolines and isoquinolines as inhibitors of raf kinase for treatment of cancer |
| 04/28/2005 | WO2005037284A1 Sorbitol dehydrogenase inhibitor and hypertensive agent combinations |
| 04/28/2005 | WO2005037283A1 Fused-aryl and heteroaryl derivatives and methods of their use |
| 04/28/2005 | WO2005037280A1 Muscarinic acetycholine receptor antagonists |
| 04/28/2005 | WO2005037279A1 1- 2’ (1, 4’-biperidin-1’-yl)-1- (phenyl) -ethyl cyclohexanol derivatives as monoamine reuptake modulators for the treatment of visomotor symptoms |
| 04/28/2005 | WO2005037278A2 Tbenazpril and amlodipine for reducing cardiovascular morbidity |
| 04/28/2005 | WO2005037277A1 A novel use of riluzole for treating retinopathy |
| 04/28/2005 | WO2005037276A1 Use of riluzole for the treatment of essential tremor |
| 04/28/2005 | WO2005037275A1 Topical compositions comprising telmesteine for treating dermatological disorders |
| 04/28/2005 | WO2005037274A1 Combination therapy for hcv infection |
| 04/28/2005 | WO2005037273A1 Substituted benzazoles and use thereof as inhibitors of raf kinase |
| 04/28/2005 | WO2005037272A1 Benzimidazole derivatives and use thereof as peptide deformylase inhibitors |
| 04/28/2005 | WO2005037271A2 Large conductance calcium-activated k channel opener |
| 04/28/2005 | WO2005037270A1 Composition for promoting synthesis of collagen, and composition for external preparation for skin comprising the same |
| 04/28/2005 | WO2005037267A1 Method of controlling paticle size of retinoic acid nanoparticles coated with polyvalent metal inorganic salt and nanoparticles obtained by the controlling method |
| 04/28/2005 | WO2005037266A1 Pharmaceutical composition comprising 5-methyl-2-(2’-chloro-6’-fluoroanilino)phenylacetic acid |
| 04/28/2005 | WO2005037265A1 Concurrent drugs |
| 04/28/2005 | WO2005037264A1 Jelly preparation containing biguanide medicine |
| 04/28/2005 | WO2005037263A1 Breast cancer treatment regimen |
| 04/28/2005 | WO2005037262A1 Citicoline-based composition in combination with vitamins for the prevention and treatment of eye pathologies |
| 04/28/2005 | WO2005037261A1 Combination therapy for cancer |
| 04/28/2005 | WO2005037260A2 Use of adrenergic alphaze antagonists for the treatment of vasomotor symptoms |
| 04/28/2005 | WO2005037259A2 Methods and compositions for the prevention or treatment of neoplasia comprising a cox-2 inhibitor in combination with an epidermal growth factor receptor antagonist |
| 04/28/2005 | WO2005037258A2 Cyanoguanidine-based azole compounds useful as malonyl-coa decarboxylase inhibitors |
| 04/28/2005 | WO2005037257A2 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/28/2005 | WO2005037256A2 Liquid preparation containing tobramycin |
| 04/28/2005 | WO2005037253A1 Process for preparing a co-precipitate of a non-crystalline solid drug substance |
| 04/28/2005 | WO2005037251A1 Self-emulsifying drug delivery systems for hydrophobic therapeutic compounds |
| 04/28/2005 | WO2005037250A1 Self emulsifying drug delivery systems for hydrophobic therapeutic compounds |
| 04/28/2005 | WO2005037249A1 Oral microemulsion composition comprising biphenyldimethyldicarboxylate and silybin |
| 04/28/2005 | WO2005037245A2 A multiple route medication for the treatment of rhinitis and asthma |
| 04/28/2005 | WO2005037230A2 Compositions and methods for treating heart failure |
| 04/28/2005 | WO2005037227A2 Selective cox-2 inhibitors |
| 04/28/2005 | WO2005037225A2 Methods for treating disorders of neuronal deficiency with bone marrow-derived cells |
| 04/28/2005 | WO2005037224A2 Muscarinic acetylcholine receptor antagonists |
| 04/28/2005 | WO2005037223A2 Methods and compositions for immunomodulation |
| 04/28/2005 | WO2005037219A2 Disinfecting teat care compositions |
| 04/28/2005 | WO2005037216A2 Bicyclic [3.1.0] derivatives as glycine transporter inhibitors |
| 04/28/2005 | WO2005037212A2 Treatment of chemical dependency with substantially nonaddicting normorphine and norcodeine derivatives |
| 04/28/2005 | WO2005037208A2 Nitrone compounds prodrugs and pharmaceutical compositions of the same to treat human disorders |
| 04/28/2005 | WO2005037207A2 Arylalkyl-piperazine derivatives for the treatment of conditions ameliorated by monoamine reuptake including vasomotor symptoms (vms) |
| 04/28/2005 | WO2005037206A2 Anti-cancer compounds and methods of use thereof |
| 04/28/2005 | WO2005037205A2 Haloacetamide and azide substituted compounds and methods of use thereof |
| 04/28/2005 | WO2005037203A2 Methods and reagents for the treatment of immunoinflammatory disorders |
| 04/28/2005 | WO2005037200A2 Composition comprising xanthoceras sorbifolia extracts, compounds isolated from same, methods for preparing same and uses thereof |
| 04/28/2005 | WO2005037198A2 Preparation of 1,7-disubstituted azabenzimidazoles as kinase inhibitors |
| 04/28/2005 | WO2005037197A2 Preperation of 1,6-disubstituted azabenzimidazoles as kinase inhibitors |
| 04/28/2005 | WO2005037196A2 Substituted 2-arylmethylene-n-aryl-n'-aryl-malonamides and analogs as activators of caspases and inducers of apoptosis |
| 04/28/2005 | WO2005037195A2 Compounds and methods for treating and preventing exercise-induced cardiac arrhythmias |
| 04/28/2005 | WO2005037193A2 Compositions of a cyclooxygenase-2 selective inhibitor administered under hypothermic conditions for the treatment of ischemic mediated central nervous system disorders or injury |
| 04/28/2005 | WO2005037189A2 Cytoplasmic activity of retinoid x receptor and its regulation by ligands and dimerization |
| 04/28/2005 | WO2005037187A2 High affinity ligands for influenza virus and methods for their production |
| 04/28/2005 | WO2005037158A1 Method for providing long-lasting pain diminishment through topical or intranasal administration of civamide |
| 04/28/2005 | WO2005037157A1 Enhancing transdermal administration of hydrophilic drugs |
| 04/28/2005 | WO2005037071A2 Receptor tyrosine kinase signaling pathway analysis for diagnosis and therapy |
| 04/28/2005 | WO2005037064A2 Use of mannan from saccharomyces cerevisiae for the treatment of asthma |
| 04/28/2005 | WO2005037052A2 Binding assay with labelled bispidine variant |
| 04/28/2005 | WO2005036989A1 Health food containing hyaluronic acid and dermatan sulfate |
| 04/28/2005 | WO2005036961A2 N-substituted azacycles |
| 04/28/2005 | WO2005025553A3 Treatment of disorders of nervous systemsystem with fty720 |
| 04/28/2005 | WO2005023826A3 Polymorphic nucleoside compounds |
| 04/28/2005 | WO2005021495A3 Quaternary salt derivatives of 1,4-diphenylazetidin-2-ones |
| 04/28/2005 | WO2005020920A3 Novel crystalline forms of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor |
| 04/28/2005 | WO2005020895A3 Method for the treatment or prevention of bone disorders with a cyclooxygenase-2 inhibitor alone and in combination with a bone disorder treatment agent and compositions therewith |
| 04/28/2005 | WO2005020887A3 Method for treatment of severe acute respiratory syndrome |
| 04/28/2005 | WO2005019163A3 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use |
| 04/28/2005 | WO2005018622A8 A pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss |
| 04/28/2005 | WO2005016877A3 Pyrazole carboxamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 04/28/2005 | WO2005014609A3 Method of producing a highly stereoregular phosphorus atom-modified nucleotide analogue |
| 04/28/2005 | WO2005013955A3 Topical composition comprising terbinafine and hydrocortisone |
| 04/28/2005 | WO2005013910A3 Cholinergic modulation of microglial activation via alpha-7 nicotinic receptors |
| 04/28/2005 | WO2005013889A3 Truncated fragments of alpha-synuclein in lewy body disease |
| 04/28/2005 | WO2005011813A3 Treatment of ocular disease |
| 04/28/2005 | WO2005011591A3 Method for the treatment of sleep disorders |
| 04/28/2005 | WO2005011581A3 Hexahydrodiazepinones as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 04/28/2005 | WO2005007137A3 Tablets containing ambroxol |
| 04/28/2005 | WO2005005398A3 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof |
| 04/28/2005 | WO2005004796A3 Sulfonylamino phenylacetamide derivatives and methods of their use |
| 04/28/2005 | WO2005003292A3 Composition and method for self-assembly and mineralization of peptide amphiphiles |
| 04/28/2005 | WO2005002524A3 COMPOUNDS, COMPOSITIONS AND THERAPEUTIC USES OF OLEOYLETHANOLAMIDE-LIKE COMPOUNDS AND MODULATORS OF PPARα |